Reaffirmed: AstraZeneca PLC (LON:AZN) Overweight Rating Maintained by Analysts at Barclays Capital; GBX 7800.00 Target in Place

AstraZeneca PLC (LON:AZN) Logo

AstraZeneca PLC (LON:AZN) Rating Reaffirmed

Recently, In analysts report sent to clients and investors on 16 August, AstraZeneca PLC (LON:AZN) shares have had their Overweight Rating kept by research professionals at Barclays Capital, who currently has a GBX 7800.00 TP on firm. This target by Barclays Capital means the possibile upside of 7.48 % from the last stock price.

AstraZeneca PLC (LON:AZN) Ratings Coverage

Among 6 analysts covering AstraZeneca PLC (LON:AZN), 2 have Buy rating, 3 Sell and 1 Hold. Therefore 33% are positive. AstraZeneca PLC has GBX 7800 highest and GBX 5000 lowest target. GBX 6288.33’s average target is -13.48% below currents GBX 7268 stock price. AstraZeneca PLC had 78 analyst reports since February 18, 2019 according to SRatingsIntel. The firm earned “Sell” rating on Wednesday, August 14 by UBS. The stock has “Buy” rating by Deutsche Bank on Thursday, May 2. The firm has “Overweight” rating given on Friday, July 26 by Barclays Capital. The firm earned “Buy” rating on Monday, February 18 by Deutsche Bank. As per Friday, May 10, the company rating was maintained by Deutsche Bank. Jefferies maintained AstraZeneca PLC (LON:AZN) rating on Friday, May 24. Jefferies has “Hold” rating and GBX 6350 target. Liberum Capital maintained the shares of AZN in report on Friday, April 5 with “Hold” rating. Goldman Sachs maintained AstraZeneca PLC (LON:AZN) on Tuesday, March 12 with “Sell” rating. The stock of AstraZeneca PLC (LON:AZN) earned “Sell” rating by Goldman Sachs on Tuesday, August 6. On Monday, July 8 the stock rating was maintained by Deutsche Bank with “Buy”.

The stock increased 0.53% or GBX 38 during the last trading session, reaching GBX 7268. About 278,378 shares traded. AstraZeneca PLC (LON:AZN) has 0.00% since August 16, 2018 and is . It has by 0.00% the S&P500.

Analysts await AstraZeneca PLC (LON:AZN) to report earnings on November, 14. They expect $0.45 earnings per share, down 36.62 % or $0.26 from last year’s $0.71 per share. AZN’s profit will be $5.90 million for 4037.78 P/E if the $0.45 EPS becomes a reality. After $0.73 actual earnings per share reported by AstraZeneca PLC for the previous quarter, Wall Street now forecasts -38.36 % negative EPS growth.

AstraZeneca PLC develops, manufactures, and commercializes prescription medicines for the treatment of oncology, cardiovascular and metabolic, respiratory, infection, gastrointestinal, and neuroscience diseases worldwide. The company has market cap of 95.35 billion GBP. The Company’s marketed products comprise Arimidex, Casodex/Cosudex, Faslodex, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Imdur, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Symlin, Xigduo, and Xigduo XR for metabolic diseases. It has a 42.45 P/E ratio. The company??s marketed products also comprise Accolate, Bevespi Aerosphere, Bricanyl Respules, Bricanyl Turbuhaler, Daliresp/Daxas, Duaklir Genuair, Eklira Genuair/Tudorza Pressair, Oxis Turbuhaler, Pulmicort Turbuhaler/Pulmicort Flexhaler, Pulmicort Respules, Symbicort pMDI, and Symbicort Turbuhaler for respiratory diseases; Fluenz Tetra/FluMist Quadrivalent and Synagis for infection diseases; Movantik/Moventig, Seroquel IR, Seroquel XR, Vimovo1, and Zomig for neuroscience diseases; and Losec/Prilosec and Nexium for gastrointestinal diseases.

More important recent AstraZeneca PLC (LON:AZN) news were published by: which released: “What Should We Expect From AstraZeneca PLC’s (LON:AZN) Earnings In The Year Ahead? – Yahoo Finance” on July 24, 2019, also published article titled: “It Might Be Better To Avoid AstraZeneca PLC’s (LON:AZN) Upcoming 1.0% Dividend – Yahoo Finance”, published: “How Much Are AstraZeneca PLC (LON:AZN) Insiders Spending On Buying Shares? – Yahoo Finance” on June 30, 2019. More interesting news about AstraZeneca PLC (LON:AZN) was released by: and their article: “What Kind Of Shareholders Own AstraZeneca PLC (LON:AZN)? – Yahoo Finance” with publication date: June 09, 2019.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.